Janeli Viil PhD

Janeli Viil scientific career began in 2004 at the University of Tartu when she joined the research group of Dr. Lilian Kadaja-Saarepuu as an undergraduate student.

During her BSc and MSc studies, She investigated the role of leukocyte markers and potential oncogene CD43 in tumor development, and its connection to the p53-dependent signaling pathway. The role of slowly-cycling liver progenitor cells and extracellular matrix in liver regeneration became the focus of her studies in the Ph.D. program under the supervision of Dr. Viljar Jaks. During this time she also had the opportunity to take part in several other projects, including cancer research, Dupuytren's contracture studies, and miRNA studies.

Janeli Viil received her Ph.D. degree in cell biology in 2016 and since April 2017 Janeli Viil working as a research fellow of clinical genomics and personalized medicine in Prof. Alireza Fazeli’s group where she studies the communication between gametes and embryos, and the maternal tract.